The Cardiovascular Diagnostic and Monitoring Devices Market in Europe was worth USD 461.29 million in 2020 and estimated to be growing at a CAGR of 6.41%, to reach 629.48 million by 2025.
Cardiovascular disease is a medical condition that affects the structure and function of organs associated with the heart's function and circulation. Cardio Vascular diseases are the primary cause of death and witnessing a high rise in prevalence. A large number of people are being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions, shifting focus towards preventative healthcare.
The European market for cardiovascular devices is majorly driven by an increasing number of people suffering from diabetes and obesity and growing risks related to hypertension and heart muscle weakening. Advancements in Technology have enabled portability features such as portability in performing various tests and adding to the growth of the Cardiovascular Monitoring market.
However, unclear reimbursement policies, stringent government regulations for product approvals, and the high cost of devices are major factors restraining market growth.
This research report on the European Cardiovascular Monitoring & Diagnostic Devices Market has been segmented and sub-segmented into the following categories:
By Product:
Based on product type, ECG systems hold the largest share in the market. They are expected to maintain it’s strong in the market during the forecast period due to widespread availability and increasing preference for diagnostic devices in developed and developing regions.
By Country:
Companies like GE Healthcare and Phillips Healthcare, Siemens Healthcare, Boston Scientific Corporation, St. Jude Medical, Inc., Nihon Kohden Corporation, and Welch Allyn, Inc. are playing a dominant role in the European Cardiovascular Monitoring & Diagnostic Devices Market.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 ECG Systems
5.1.1.1 Resting ECG Systems
5.1.1.2 Stress ECG Systems
5.1.2 Event Monitors
5.1.3 Holter Monitors
5.1.4 Implantable Loop Recorders
5.1.5 ECG Management Systems
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Philips Healthcare
8.3 Siemens Healthcare
8.4 Boston Scientific Corporation
8.5 St. Jude Medical, Inc
8.6 Nihon Kohden Corporation
8.7 Welch Allyn, Inc.
8.8 Spacelabs Healthcare
8.9 LivaNova PLC
8.10 Hill-Rom Holdings, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
